Neoadjuvant Chemoradiotherapy Followed by Chemotherapy With or Without Tislelizumab for Resectable Ultra-low Rectal Cancer: The RELIEVE-02 Study
Clinical trial NCT07132463 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07132463
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-01
- Primary completion
- 2027-12-01
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.